Navigation Links
Dr. Neil Sadick Presents on Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
Date:2/6/2008

NAPA, Calif., Feb. 6 /PRNewswire-FirstCall/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today announced that Dr. Neil Sadick presented on Pyratine-6(TM) at the 66th Annual Meeting of the American Academy of Dermatology in San Antonio, Texas.

In his presentation to the Academy, Dr. Sadick, a prominent New York dermatologist, outlined the therapeutic benefits of Senetek's Pyratine-6(TM) for the treatment of aging skin. Dr. Sadick reviewed clinical data demonstrating the ability of Pyratine-6(TM) to ameliorate the visible signs of skin aging and significantly reduce erythema -- redness of the skin caused by capillary congestion.

In independent clinical trials at the University of California, Irvine and RCTS, an independent laboratory in Irving, Texas, Pyratine-6(TM) demonstrated significant efficacy in the treatment of fine wrinkles, skin roughness, acne lesions, overall skin aging, and significantly reduced erythema as early as two weeks from onset of use. Pyratine-6(TM) was also shown to increase skin moisture content and was well tolerated by all subjects producing no measurable skin irritation or signs of allergic contact dermatitis with twice-daily application over the 12-week study periods.

Frank Massino, Chairman and Chief Executive Officer of Senetek stated, "We are very pleased by the recognition Pyratine-6(TM) has received at this important dermatological symposium."

About Senetek PLC

Senetek PLC (OTCBB: SNKTY) is a Life Sciences company engaged in the development of breakthrough technologies that target the science of healthy aging. The Company's extensive research collaborations have resulted in a strong pipeline of patented compounds and products with broad therapeutic applications and a leading presence in dermatology. Senetek collaborates with established specialty pharmaceutical companies in the final dev
'/>"/>

SOURCE Senetek PLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Bush Budget Represents Double Whammy Hit on U.S. Seniors Medicare-Financed Nursing Facility Care
2. Womans Day Presents the 5th Annual Red Dress Awards Honoring Women Who Are Leaders in the Fight Against Heart Disease
3. Center for Science Writings presents: Big Fat Lies: The Truth about Diet, Exercise and Obesity
4. IQWiG presents a concept for cost-benefit assessment methods in the German health care system
5. Illness Presents Diabetics With Special Challenges
6. A New Book on Sexual Medicine Calls Attention to The Couple and Presents State-of-the Art Treatments for Sexual Dysfunction
7. GlaxoSmithKline Presents Innovative Neuroscience Pipeline
8. EntreMed Presents Results for ENMD-1198 and Vincristine in Preclinical Leukemia Models
9. New book presents comprehensive survey of research into the molecular basis of aging
10. NHCAA Presents 2007 Fraud Investigation of the Year Award to U.S. Departments of Justice, HHS, and Treasury for Convicting Internet Pharmacy Drug Kingpin
11. National Partners from St. Jude Halloween Promotion Presents More Than $1.7 Million to Help Fight Childhood Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... Note: Dr. Julian is available for interviews ... , A phase III trial funded by the National ... carcinoma in situ (DCIS) now have an additional tool ... (NSABP B-35/NRG Oncology) looked at more than 3,000 DCIS ... with tamoxifen to those who completed five years of ...
(Date:6/1/2015)... More than 22 million children may miss out on milk’s ... they lose access to free or reduced-price meal programs. June ... companies are on a mission to bring more nutritious milk ... , In many cases, food insecure children depend on ... bulk of their daily nutrition. Although the National School Lunch ...
(Date:6/1/2015)... GA (PRWEB) June 01, 2015 June ... publisher of clinical journals in the areas of hospital ... to announce that it has expanded upon its partnership ... journal, Hospital Medicine Practice, in a mobile application ... and tablets. , “We are very excited about ...
(Date:6/1/2015)... GA. (PRWEB) June 01, 2015 Hexagon ... Online, which is a new cloud-based subscription service that ... and GIS software. , Both ERDAS IMAGINE ... access through Producer Online, which offers a subscription model ... “Today’s organizations need to be able to quickly and ...
(Date:6/1/2015)... 2015 A University of Texas ... signaling proteins that activate protein degradation, which helps ... 1 , The study published April 3rd ... Spraque-Dawley rats 2-3 months of age who performed ... given either whey protein (.4g/kg), low-dose Sustamine (.1g/kg), ...
Breaking Medicine News(10 mins):Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 2Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 3Health News:Summer Nutrition Vital for Kids who Depend on Schools for Healthy Foods 2Health News:EB Medicine Expands Partnership With AgileMD To Launch Hospital Medicine Mobile Application 2Health News:EB Medicine Expands Partnership With AgileMD To Launch Hospital Medicine Mobile Application 3Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 2Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 3Health News:Study Shows Taking Sustamine® L-Alanyl-L-Glutamine May Reduce Muscle Protein Breakdown After Resistance Exercise 2Health News:Study Shows Taking Sustamine® L-Alanyl-L-Glutamine May Reduce Muscle Protein Breakdown After Resistance Exercise 3
... The Australian Medical Students’ Association (AMSA) is hosting the ... Students’ Associations (IFMSA).// ,Medical students from 70 ... for the commencement of the biannual conference. AMSA is ... last year in Santiago, Chile. ,Representing ...
... Perkins is on top of the world, literally. ... mountaineering feats, as she scaled another mountain peak,// this time in ... She led her team up one of several unnamed peaks in ... more than 650 miles west of Buenos Aires. ,Perkins ...
... in protest of a new smoking ban to hit the nation-and ... July first onwards, actors will be allowed to light up only ... ,This, believes Equity, the Actors union, is unfair. Says spokes ... performers should be able to rehearse properly with any prop, including ...
... stress can damage a child's brain, say researchers at ... //Children's Hospital. The researchers found that children with post-traumatic ... cortisol were likely to experience a decrease in the ... in memory processing and emotion. ,Although similar ...
... More things are wrought by prayers than the world dreams of ... ,"It's a known fact that golf maestro Tiger Woods meditates and ... marketing at Le Meriden Gokarna Forest Golf Resort and Spa, Kathmandu's ... very much a mind game." ,So to help golfers ...
... a provisional safety rating until their safety and ... experts have said in the latest Medical Journal ... and some other prescription medicines, which were withdrawn ... reliance on pre-marketing trials and voluntary adverse reaction ...
Cached Medicine News:Health News:Severe PTSD Damages Children's Brains: Study 2Health News:Severe PTSD Damages Children's Brains: Study 3Health News:Nepal to Introduce Art of Living for Golfers 2Health News:Time to Overhaul Australia's Medicines Safety Surveillance System 2
(Date:6/1/2015)... 2015 NSHOA Cancer Center and Heron ... positive, top-line results from its recently completed Phase ... safety of the Company,s 5-HT 3 receptor ... extended release) as part of a three-drug regimen ... receptor antagonist fosaprepitant and the IV corticosteroid dexamethasone ...
(Date:6/1/2015)... , June 1, 2015   OTC ... Open, Transparent and Connected financial marketplaces for 10,000 ... a San Diego -based biopharmaceutical ... on OTCQB®, America,s only public venture market for ... - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO "We,re ...
(Date:6/1/2015)... MENLO PARK, Calif. , June 1, ... ("DelMar" and the "Company"), a biopharmaceutical company focused on ... drug indications, announced that it will be hosting a ... 1, 2015, at 5:30 p.m. CDT (6:30 p.m. EDT). ... I/II study of VAL-083 (dianhydrogalactitol) in patients ...
Breaking Medicine Technology:New cancer therapy study results - MAGIC Trial 2OTC Markets Group Congratulates OncoSec Medical on NASDAQ Listing 2DelMar Pharmaceuticals to Host Investor Conference Call on June 1, 2015 to Discuss New VAL-083 Phase I/II Clinical Data in Patients with Refractory Glioblastoma Multiforme 2DelMar Pharmaceuticals to Host Investor Conference Call on June 1, 2015 to Discuss New VAL-083 Phase I/II Clinical Data in Patients with Refractory Glioblastoma Multiforme 3DelMar Pharmaceuticals to Host Investor Conference Call on June 1, 2015 to Discuss New VAL-083 Phase I/II Clinical Data in Patients with Refractory Glioblastoma Multiforme 4
Only Mentors reusable Alpine Leg Bag has patented Kraylex odor barrier, offset port options, and integrated loops providing total confidence and comfort....
... Freedom leg bags are part of ... versatile line of leg bags, kits, ... varied needs of our customers. These ... sizes, and constructed of 100% latex-free ...
... Freedom leg bags are part of ... versatile line of leg bags, kits, ... varied needs of our customers. These ... sizes, and constructed of 100% latex-free ...
... bags are part of the Freedom ... of leg bags, kits, and accessories ... of our customers. These leg bags ... constructed of 100% latex-free soft, textured ...
Medicine Products: